Skip to main content

Advertisement

Table 1 Baseline characteristics and associated mortality among patients with chronic hepatitis B who started antiviral treatment in Ethiopia

From: Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study

Characteristics Number of patients (%) (n = 276) Number of deaths (%) (n = 35)
Sex
 Male 215 (77.9) 29 (82.9)
 Female 61 (22.1) 6 (17.1)
Age (years)
 18–25 58 (21.0) 4 (11.4)
 26–35 101 (36.6) 11 (31.4)
 36–45 63 (22.8) 9 (25.7)
  > 45 54 (19.6) 11 (31.4)
ALT (U/L)
  < 40 163 (59.1) 19 (54.3)
  40–79 78 (28.3) 11 (31.4)
  ≥ 80 35 (12.7) 5 (14.3)
Body mass index (kg/m2)a
  < 18.5 57 (21.2) 14 (41.2)
  ≥ 18.5 212 (78.8) 20 (58.8)
HBV viral load (IU/m)b
  < 2000 85 (30.8) 12 (34.3)
 2000-19,999 42 (15.2) 2 (5.7)
  ≥ 20,000 149 (54.0) 21 (60.0)
Transient elastography (kPa)
  < 8.0 50 (19.2) 1 (3.1)
 8.0–9.9 37 (14.2) 1 (3.1)
  ≥ 10.0 173 (66.5) 30 (93.8)
Cirrhosis assessment
 No cirrhosis 86 (31.2) 1 (2.9)
 Compensated cirrhosisd 74 (26.8) 1 (2.9)
 Decompensated cirrhosise 116 (42.0) 33 (94.3)
  1. an = 269; bn = 251; cn = 260. dDefined as transient elastography ≥10.0 kPa. eDefined as clinical/ultrasonographic evidence of ascites
  2. ALT alanine aminotransferase, HBV hepatitis B virus